17-allylamino-17-demethoxygeldanamycin(English)

• HSP90 inhibitor that has been shown to have promising results in antitumor activity through the degradation of the activated V600E mutant of B-Raf (V600E B-Raf) in cutaneous melanoma cell lines
• MTT, siRNA, HSP90
• Dermatology, Oncology, Ophthalmology
• https://doi.org…67/iovs.07-1305